Physician profile
Henry C Wu
NPI 1093179004
$5,082.96
in general payments reported to CMS, 2019-2025
21 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $104 · 2021: $1,124 · 2022: $1,218 · 2023: $1,128 · 2024: $1,322 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,185 · Travel and Lodging: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.07 |
| Travel and Lodging | $452.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $1,051.37 | 2022 | |
| Abbott Laboratories | $1,021.00 | 2021-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $876.50 | 2020-2024 | |
| Nevro Corp. | $404.82 | 2021 | |
| Saluda Medical Americas, INC. | $332.75 | 2021-2024 | Evoke |
| Averitas Pharma INC. | $328.36 | 2023-2024 | Qutenza |
| Vertos Medical, INC. | $232.67 | 2022-2024 | Mild Device Kit |
| Medtronic, INC. | $177.12 | 2021-2022 | |
| Nalu Medical, INC. | $145.71 | 2021-2024 | Nalu Neurostimulation System |
| Electronic Waveform Lab, INC. | $125.27 | 2025 | |
| Stimwave Technologies Incorporated | $73.10 | 2021 | |
| Collegium Pharmaceutical, INC. | $72.92 | 2021-2025 | Belbuca, Xtampza |
| Grt US Holding, INC. | $58.30 | 2021-2022 | |
| Stryker Corporation | $38.71 | 2021 | |
| Spr Therapeutics, INC | $31.35 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $26.00 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $20.52 | 2022 | |
| Acacia Pharma INC | $18.87 | 2021 | |
| Valinor Pharma, LLC | $18.42 | 2024 | Movantik |
| Redhill Biopharma INC. | $16.71 | 2021 | |
| Relievant Medsystems, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.